Lantu Biopharma
Clinical trials sponsored by Lantu Biopharma, explained in plain language.
-
New gene therapy for SMA tested in low-income countries
Disease control Recruiting nowThis study looks at how well a gene therapy called Vesemnogene lantuparvovec works for people with spinal muscular atrophy (SMA) in low- and middle-income countries. Researchers will track safety and whether patients reach key motor milestones. About 15 participants will be follo…
Phase: PHASE3 • Sponsor: Lantu Biopharma • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
Gene therapy may free Beta-Thalassemia patients from lifelong transfusions
Disease control Recruiting nowThis early-stage study tests a one-time gene therapy for people with a severe form of beta-thalassemia that requires regular blood transfusions. The treatment uses the patient's own blood stem cells, which are modified in a lab to produce healthy hemoglobin. The goal is to see if…
Phase: PHASE1, PHASE2 • Sponsor: Lantu Biopharma • Aim: Disease control
Last updated May 26, 2026 08:30 UTC